GoodRx Holdings (GDRX) Operating Margin (2019 - 2026)

GoodRx Holdings has disclosed Operating Margin across 8 years of filings, most recently posting 7.22% for Q1 2026.

• Operating Margin for Q1 2026 came in at 7.22%, down 430.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.92% (down 35.0% YoY), and the FY2025 annual result was 10.98%, up 267.0% from the prior year.
• Operating Margin came in at 7.22% for Q1 2026 at GoodRx Holdings, down from 11.65% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 13.2% in Q2 2025 to a low of 21.3% in Q3 2023.
• The 5-year median for Operating Margin is 7.46% (2025), against an average of 4.1%.
• Across the five-year window, Operating Margin sank 1291 bps in 2023 and jumped 3175 bps in 2024, its largest moves.
• GoodRx Holdings' Operating Margin stood at 0.94% in 2022, then sank by 1086 bps to 9.3% in 2023, then soared by 198 bps to 9.15% in 2024, then rose by 27 bps to 11.65% in 2025, then plunged by 38 bps to 7.22% in 2026.
• The last three Operating Margin figures came in at 7.22% (Q1 2026), 11.65% (Q4 2025), and 7.46% (Q3 2025), per Business Quant data.